Teladoc Stock Return On Equity
TDOC Stock | USD 13.74 0.44 3.31% |
Teladoc fundamentals help investors to digest information that contributes to Teladoc's financial success or failures. It also enables traders to predict the movement of Teladoc Stock. The fundamental analysis module provides a way to measure Teladoc's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Teladoc stock.
Last Reported | Projected for Next Year | ||
Return On Equity | (0.09) | (0.1) |
Teladoc | Return On Equity |
Teladoc Company Return On Equity Analysis
Teladoc's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Teladoc Return On Equity | -0.0951 |
Most of Teladoc's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Teladoc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Teladoc Return On Equity Driver Correlations
Understanding the fundamental principles of building solid financial models for Teladoc is extremely important. It helps to project a fair market value of Teladoc Stock properly, considering its historical fundamentals such as Return On Equity. Since Teladoc's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Teladoc's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Teladoc's interrelated accounts and indicators.
Click cells to compare fundamentals
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition |
Teladoc Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, Teladoc has a Return On Equity of -0.0951. This is 99.6% lower than that of the Health Care Technology sector and significantly lower than that of the Health Care industry. The return on equity for all United States stocks is 69.32% lower than that of the firm.
Teladoc Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Teladoc's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Teladoc could also be used in its relative valuation, which is a method of valuing Teladoc by comparing valuation metrics of similar companies.Teladoc is currently under evaluation in return on equity category among related companies.
Teladoc Current Valuation Drivers
We derive many important indicators used in calculating different scores of Teladoc from analyzing Teladoc's financial statements. These drivers represent accounts that assess Teladoc's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Teladoc's important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 6.0B | 18.1B | 14.4B | 3.8B | 3.5B | 5.7B | |
Enterprise Value | 6.0B | 18.8B | 14.8B | 4.5B | 4.0B | 5.9B |
Teladoc Fundamentals
Return On Equity | -0.0951 | ||||
Return On Asset | -0.0301 | ||||
Profit Margin | (0.08) % | ||||
Operating Margin | (0.05) % | ||||
Current Valuation | 2.69 B | ||||
Shares Outstanding | 169.31 M | ||||
Shares Owned By Insiders | 0.76 % | ||||
Shares Owned By Institutions | 71.56 % | ||||
Number Of Shares Shorted | 20.88 M | ||||
Price To Earning | (21.84) X | ||||
Price To Book | 1.03 X | ||||
Price To Sales | 0.92 X | ||||
Revenue | 2.6 B | ||||
Gross Profit | 1.66 B | ||||
EBITDA | 192.05 M | ||||
Net Income | (220.37 M) | ||||
Cash And Equivalents | 883.7 M | ||||
Cash Per Share | 5.47 X | ||||
Total Debt | 1.59 B | ||||
Debt To Equity | 0.26 % | ||||
Current Ratio | 3.38 X | ||||
Book Value Per Share | 13.96 X | ||||
Cash Flow From Operations | 350.02 M | ||||
Short Ratio | 5.01 X | ||||
Earnings Per Share | (1.34) X | ||||
Price To Earnings To Growth | (1.01) X | ||||
Target Price | 19.7 | ||||
Number Of Employees | 4.82 K | ||||
Beta | 0.94 | ||||
Market Capitalization | 2.25 B | ||||
Total Asset | 4.39 B | ||||
Retained Earnings | (15.23 B) | ||||
Working Capital | 1.07 B | ||||
Current Asset | 151.58 M | ||||
Current Liabilities | 17.99 M | ||||
Net Asset | 4.39 B |
About Teladoc Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Teladoc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Teladoc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Teladoc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Teladoc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Teladoc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Teladoc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Teladoc Stock:Check out Teladoc Piotroski F Score and Teladoc Altman Z Score analysis. For information on how to trade Teladoc Stock refer to our How to Trade Teladoc Stock guide.You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Complementary Tools for Teladoc Stock analysis
When running Teladoc's price analysis, check to measure Teladoc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teladoc is operating at the current time. Most of Teladoc's value examination focuses on studying past and present price action to predict the probability of Teladoc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teladoc's price. Additionally, you may evaluate how the addition of Teladoc to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |
Is Teladoc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Teladoc. If investors know Teladoc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Teladoc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.34) | Revenue Per Share 15.813 | Quarterly Revenue Growth 0.036 | Return On Assets (0.03) | Return On Equity (0.1) |
The market value of Teladoc is measured differently than its book value, which is the value of Teladoc that is recorded on the company's balance sheet. Investors also form their own opinion of Teladoc's value that differs from its market value or its book value, called intrinsic value, which is Teladoc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Teladoc's market value can be influenced by many factors that don't directly affect Teladoc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Teladoc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Teladoc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Teladoc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.